CW November 2003Issue Number 11 November 2003 ISSN 10593802 Circadian Clock Genes may Provide Targets for Cancer DrugsCircadian rhythmicity in mammals is a complex phenomenon and is under the control of a molecular pacemaker consisting of clock gene products organized in autoregulatory loops. Clock genes are found to coordinate many basic functions such as cell proliferation and apoptosis. Cancer cells and normal cells are also thought to follow different circadian rhythms. The rhythmical expression of certain key regulatory proteins in cancer cells can be used to target cancer drugs.
Go to Previous Page Go to Next Page Source & Additional Reading S. You et al., American Association of Cancer Research held in Boston, MA, November 17-21, 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW November 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |